Hafez Selim
Every periodic benefit-risk evaluation report ends with a conclusion about whether a medicine’s benefits continue to outweigh its risks. Assessors read that conclusion first, then read everything else to decide whether they believe it.The PBRER Handbook is a practical, safety-led guide to the judgments behind a credible PBRER or PSUR. Written by a senior safety physician with more than twenty years in the pharmaceutical and medical device industries, it goes beyond what belongs under each ICH E2C(R2) heading to show how to weigh evidence, how much of that judgment to put on paper, and what to say when the evidence is not yet decisive.The book follows the report from planning to the final assessor question, treating it as one argument rather than twenty separate sections. It teaches through four recurring fictional cases - two small molecules and two biologics - so readers can see how a decision about exposure shapes a risk conclusion and, later, a response to a health authority.Inside you will find:A six-question method for moving from evidence to a defensible conclusionWorked examples with a weak draft, an improved draft, and reviewer commentaryChapters on exposure, summary tabulations, signal evaluation, risk characterization, risk-minimization effectiveness, benefit evaluation, and integrated benefit-riskScientific review, quality control, and responding to health-authority questionsRegional requirements for the European Union, United States, United Kingdom, Canada, and AustraliaSection blueprints, a regional applicability matrix, case data packs, a template package index, glossary, and regulatory source registerFor safety physicians, pharmacovigilance scientists, medical writers, regulatory-affairs professionals, and QPPVs who prepare, review, or approve periodic safety reports.